Understanding liver disease progression in Korean Americans with Hepatitis B
Bio-Psycho-Social Drivers of Disparities in Liver Disease Progression among Korean Americans with Hepatitis B Infection
['FUNDING_R01'] · THOMAS JEFFERSON UNIVERSITY · NIH-10820466
This study is looking at how different factors, like health, emotions, and social support, affect the progression of liver disease in Korean Americans with Hepatitis B, to better understand why some people may experience worse health outcomes than others.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | THOMAS JEFFERSON UNIVERSITY (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10820466 on ClinicalTrials.gov |
What this research studies
This research investigates the complex factors that contribute to liver disease progression among Korean Americans infected with Hepatitis B. It aims to explore how biological, psychological, and social elements interact to affect health outcomes in this population. By examining two unique patient cohorts, the study will identify the various pathways leading to disparities in chronic liver disease. The approach includes a longitudinal analysis to track changes over time and understand the multifaceted nature of this health issue.
Who could benefit from this research
Good fit: Ideal candidates for this research are Korean Americans diagnosed with chronic Hepatitis B infection.
Not a fit: Patients who do not have Hepatitis B or those outside the Korean American community may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing liver disease in Korean Americans, ultimately reducing health disparities.
How similar studies have performed: Previous research has shown that addressing multifactorial influences on chronic diseases can lead to significant improvements in patient outcomes, suggesting this approach may be effective.
Where this research is happening
PHILADELPHIA, UNITED STATES
- THOMAS JEFFERSON UNIVERSITY — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JUON, HEE-SOON — THOMAS JEFFERSON UNIVERSITY
- Study coordinator: JUON, HEE-SOON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: chronic disorder, Chronic Disease, Infectious Disease Pathway, Infectious Diseases